1. Home
  2. Stock quotes
  3. BioCryst Pharmaceuticals
  4. Financial Statements
  5. Balance Sheet
  6. Cash and Cash Equivalents
BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals BCRX
$ 7.6 1.4%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-05-2024

report update icon

BioCryst Pharmaceuticals Cash and Cash Equivalents 2011-2024 | BCRX

Annual Cash and Cash Equivalents BioCryst Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
111 M 305 M 504 M 272 M 114 M 26.7 M 50.3 M 22.1 M 28.9 M 54.5 M 21.2 M 20.9 M 16.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
504 M 16.4 M 119 M

Quarterly Cash and Cash Equivalents BioCryst Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
96.8 M 78.4 M 84.3 M 111 M 151 M 146 M 155 M 305 M 247 M - 396 M 504 M 200 M 210 M 227 M 272 M 272 M 272 M 272 M 114 M 114 M 114 M 114 M 26.7 M 26.7 M 26.7 M 26.7 M 50.3 M 50.3 M 50.3 M 50.3 M 22.1 M 22.1 M 22.1 M 22.1 M 28.9 M 28.9 M 28.9 M 28.9 M 54.5 M 54.5 M 54.5 M 54.5 M 21.2 M 21.2 M 21.2 M 21.2 M 20.9 M 20.9 M 20.9 M 20.9 M 16.4 M 16.4 M 16.4 M 16.4 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
504 M 16.4 M 100 M